OVERVIEW
The Global Human Microbiome Market is calculated to reach $73.89 billion by 2024, at a CAGR of 8.96% during the forecast period 2019-2024. The demand for increased productivity & reduce downtime in industrial facilities & manufacturing activities worldwide are analyzed to drive the market for actuators globally. The growing deployment of advanced & cost-effective actuators and increasing demand for industrial robots & process automation in industrial verticals are some of the opportunities impacting the growth of the Human Microbiome Market.
TABLE OF CONTENT
1 Global Human Microbiome Market – Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Human Microbiome Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Human Microbiome Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Human Microbiome Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Human Microbiome Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Growing awareness about human microbiome therapy
6.2.1.2 Increasing incidence of lifestyle-related diseases
6.2.1.3 Growing geriatric population
6.2.2 Restraints
6.2.2.1 Lack of comprehensive research
6.2.3 Opportunities
6.2.3.1 Investigational New Drug (IND) requirements for fecal microbiota
6.2.4 Challenges
6.2.4.1 Stringent government regulations
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Human Microbiome Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Human Microbiome Market – By Product (Market Size – & million/billion)
8.1 Probiotics
8.2 Foods
8.3 Prebiotics
8.4 Medical Foods
8.5 Diagnostic Devices
8.6 Drugs
8.7 Other
9 Global Human Microbiome Market – By Technology
9.1 Cell Culture Technology
9.2 High-Throughput Technology
9.3 Omics Technology
9.4 Computational Tools
10 Global Human Microbiome Market – By Disease
10.1 Obesity
10.2 Diabetes
10.3 Autoimmune Disorder
10.4 Cancer
10.5 Gastrointestinal Disorders
10.6 Central Nervous System Disorders
10.7 Other Diseases
11 Global Human Microbiome Market – By Application
11.1 Therapeutics
11.2 Diagnostics
12 Global Human Microbiome Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Human Microbiome Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Human Microbiome Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Yakult Honsha Co. Ltd
14.3 Synthetic Biologics Inc.
14.4 Enterome Bioscience
14.5 Merck & Co., Inc.
14.6 DuPont
14.7 Metabiomics Corporation
14.8 Seres Therapeutics
14.9 Second Genome
14.10 Microbiome Therapeutics, LLC
14.11Osel, Inc.
14.12 Company 11 & more
“* Private Company Financials would be provided on our best efforts”
15 Global Human Microbiome Market – Appendix
15.1 Sources
15.2 Abbreviations
